Ironwood Pharma (NASDAQ: IRWD) reported Q4 EPS of $0.27, $0.08 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $117.13 million versus the consensus estimate of $109.87 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.